Form 8-K - Current report:
SEC Accession No. 0001157523-10-001229
Filing Date
2010-02-25
Accepted
2010-02-25 16:06:52
Documents
2
Period of Report
2010-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. 8-K a6193690.htm 8-K 16441
2 EXHIBIT 99.1 a6193690ex99_1.htm EX-99.1 95668
  Complete submission text file 0001157523-10-001229.txt   113686
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50743 | Film No.: 10633672
SIC: 2834 Pharmaceutical Preparations